Skip to content
Infection and Cancer

Publications

2024

  1. Pikkujämsä, H, Luukkaala, T, Nyberg, RH, Louvanto, K. COVID-19 pandemic impact on gynecologic cancer treatment pathways in a Finnish tertiary center. Acta Obstet Gynecol Scand. 2024;103 (12):2566-2575. doi: 10.1111/aogs.14981. PubMed PMID:39356038 PubMed Central PMC11609985.
  2. Suominen, H, Syrjänen, K, Waterboer, T, Grénman, S, Syrjänen, S, Louvanto, K et al.. Serum Immunoglobulin G Antibodies to Human Papillomavirus Type 6 L1, E2, E4, E6, and E7 Proteins Among Children Prospectively Followed up for 3 Years. J Infect Dis. 2024;230 (6):e1207-e1213. doi: 10.1093/infdis/jiae293. PubMed PMID:38820118 PubMed Central PMC11646598.
  3. Louvanto, K, Verhoef, L, Pimenoff, V, Eriksson, T, Leppälä, S, Lagheden, C et al.. Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions. Int J Cancer. 2024;155 (9):1549-1557. doi: 10.1002/ijc.35044. PubMed PMID:38801336 .
  4. Kirjavainen, L, Suominen, H, Syrjänen, K, Waterboer, T, Grenman, S, Syrjänen, S et al.. Impact of Different Cofactors on Naturally Acquired Human Papillomavirus Antibody Levels Among Unvaccinated Pregnant Women. Viral Immunol. 2024;37 (1):36-43. doi: 10.1089/vim.2023.0108. PubMed PMID:38315747 .
  5. Taavela, K, Eriksson, T, Huhtala, H, Bly, A, Harjula, K, Heikkilä, K et al.. The quality of life of frequently vs. infrequently screened HPV vaccinated women. Qual Life Res. 2024;33 (4):941-949. doi: 10.1007/s11136-023-03575-y. PubMed PMID:38238599 PubMed Central PMC10973058.
  6. Suominen, NT, Luukkaala, TH, Laprise, C, Haataja, MA, Grénman, SE, Syrjänen, SM et al.. Human Papillomavirus Concordance Between Parents and Their Newborn Offspring: Results From the Finnish Family Human Papillomavirus Study. J Infect Dis. 2024;229 (2):448-456. doi: 10.1093/infdis/jiad330. PubMed PMID:37562006 PubMed Central PMC10873173.

Search PubMed

2023

  1. Pimenoff, VN, Gray, P, Louvanto, K, Eriksson, T, Lagheden, C, Söderlund-Strand, A et al.. Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts. Cell Host Microbe. 2023;31 (11):1921-1929.e3. doi: 10.1016/j.chom.2023.10.001. PubMed PMID:37944494 .
  2. Bergqvist, L, Heinonen, A, Carcopino, X, Redman, C, Aro, K, Kiviharju, M et al.. Added value of electrical impedance spectroscopy in adjunction of colposcopy: a prospective cohort study. BMJ Open. 2023;13 (10):e074921. doi: 10.1136/bmjopen-2023-074921. PubMed PMID:37899156 PubMed Central PMC10619076.
  3. Suominen, H, Suominen, N, Syrjänen, K, Waterboer, T, Grénman, S, Syrjänen, S et al.. Effect of a Second Pregnancy on the HPV Serology in Mothers Followed Up in the Finnish Family HPV Study. Viruses. 2023;15 (10):. doi: 10.3390/v15102109. PubMed PMID:37896886 PubMed Central PMC10612095.
  4. Laine, HK, Waterboer, T, Syrjänen, K, Grenman, S, Louvanto, K, Syrjänen, S et al.. IgG Seroreactivites to Viral Capsid Protein VP1 of JC and BK Polyomaviruses in Children at Early Ages with Special Reference to Parental Cofactors. Children (Basel). 2023;10 (10):. doi: 10.3390/children10101645. PubMed PMID:37892308 PubMed Central PMC10604957.
  5. Suominen, NT, Roger, M, Faucher, MC, Syrjänen, KJ, Grénman, SE, Syrjänen, SM et al.. HLA-G Alleles Impact the Perinatal Father-Child HPV Transmission. Curr Issues Mol Biol. 2023;45 (7):5798-5810. doi: 10.3390/cimb45070366. PubMed PMID:37504282 PubMed Central PMC10378566.
  6. Laine, HK, Waterboer, T, Syrjänen, K, Grenman, S, Louvanto, K, Syrjänen, S et al.. Human polyomavirus BKPyV and JCPyV serostatus has no impact on women´s human papillomavirus infection outcome. Front Cell Infect Microbiol. 2023;13 :1190019. doi: 10.3389/fcimb.2023.1190019. PubMed PMID:37333846 PubMed Central PMC10272380.
  7. Malagón, T, Trottier, H, El-Zein, M, Villa, LL, Franco, EL, Ludwig-McGill Cohort Study et al.. Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women. J Infect Dis. 2023;228 (4):402-411. doi: 10.1093/infdis/jiad043. PubMed PMID:36790831 PubMed Central PMC10428201.
  8. Laine, HK, Waterboer, T, Syrjänen, K, Grenman, S, Louvanto, K, Syrjänen, S et al.. Seroprevalence of polyomaviruses BK and JC in Finnish women and their spouses followed-up for three years. Sci Rep. 2023;13 (1):879. doi: 10.1038/s41598-023-27850-7. PubMed PMID:36650213 PubMed Central PMC9845201.
  9. Rintala, S, Dahlstrom, KR, Franco, EL, Louvanto, K. A synthesis of evidence for cancer-specific screening interventions: A Preventive Medicine Golden Jubilee Review. Prev Med. 2023;167 :107395. doi: 10.1016/j.ypmed.2022.107395. PubMed PMID:36565859 .
  10. El-Zein, M, Bouten, S, Abdrabo, LS, Siblini, A, Louvanto, K, Franco, E et al.. Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions. J Low Genit Tract Dis. 2023;27 (1):12-18. doi: 10.1097/LGT.0000000000000706. PubMed PMID:36205321 .
  11. Lehtinen, M, Pimenoff, VN, Nedjai, B, Louvanto, K, Verhoef, L, Heideman, DAM et al.. Assessing the risk of cervical neoplasia in the post-HPV vaccination era. Int J Cancer. 2023;152 (6):1060-1068. doi: 10.1002/ijc.34286. PubMed PMID:36093582 PubMed Central PMC10091767.

Search PubMed

2022

  1. Rintala, S, Dahlstrom, KR, Franco, EL, Louvanto, K. A synthesis of evidence for cancer-specific screening interventions: A Preventive Medicine Golden Jubilee Review. Prev Med. 2023;167 :107395. doi: 10.1016/j.ypmed.2022.107395. PubMed PMID:36565859 .
  2. Suominen, H, Paaso, A, Koskimaa, HM, Grénman, S, Syrjänen, K, Syrjänen, S et al.. Peripheral Blood T-lymphocyte Phenotypes in Mother-Child Pairs Stratified by the Maternal HPV Status: Persistent HPV16 vs. HPV-Negative: A Case-Control Study. Viruses. 2022;14 (12):. doi: 10.3390/v14122633. PubMed PMID:36560637 PubMed Central PMC9788282.
  3. Pirttilä, T, Syrjänen, S, Louvanto, K, Loimaranta, V. Longitudinal Dynamics of HPV16 Antibodies in Saliva and Serum among Pregnant Women. Viruses. 2022;14 (11):. doi: 10.3390/v14112567. PubMed PMID:36423177 PubMed Central PMC9693129.
  4. El-Zein, M, Bouten, S, Abdrabo, LS, Siblini, A, Louvanto, K, Franco, E et al.. Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions. J Low Genit Tract Dis. 2023;27 (1):12-18. doi: 10.1097/LGT.0000000000000706. PubMed PMID:36205321 .
  5. Lehtinen, M, Pimenoff, VN, Nedjai, B, Louvanto, K, Verhoef, L, Heideman, DAM et al.. Assessing the risk of cervical neoplasia in the post-HPV vaccination era. Int J Cancer. 2023;152 (6):1060-1068. doi: 10.1002/ijc.34286. PubMed PMID:36093582 PubMed Central PMC10091767.
  6. Vuorinen, S, Syrjänen, K, Waterboer, T, Grénman, S, Syrjänen, S, Louvanto, K et al.. Outcomes of HPV type-specific serostatus do not associate with oral or genital HPV-carriage in non-vaccinated women followed for three years. BMC Womens Health. 2022;22 (1):141. doi: 10.1186/s12905-022-01717-x. PubMed PMID:35484584 PubMed Central PMC9052499.
  7. Lehtinen, M, Gray, P, Louvanto, K, Vänskä, S. In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers. Expert Rev Vaccines. 2022;21 (6):735-738. doi: 10.1080/14760584.2022.2064279. PubMed PMID:35404177 .
  8. Louvanto, K, Baral, P, Burchell, A, Ramanakumar, A, El-Zein, M, Tellier, PP et al.. Role of Human Leukocyte Antigen Allele Sharing in Human Papillomavirus Infection Transmission Among Heterosexual Couples: Findings From the HITCH Cohort Study. J Infect Dis. 2022;226 (7):1175-1183. doi: 10.1093/infdis/jiac115. PubMed PMID:35363864 PubMed Central PMC9518836.
  9. Syrjänen, S, Waterboer, T, Rintala, M, Pawlita, M, Syrjänen, K, Louvanto, K et al.. Maternal HPV-antibodies and seroconversion to HPV in children during the first 3 years of life. Sci Rep. 2022;12 (1):2227. doi: 10.1038/s41598-022-06343-z. PubMed PMID:35140326 PubMed Central PMC8828864.
  10. Suominen, NT, Jaakola, AJ, Roger, M, Faucher, MC, Syrjänen, KJ, Grénman, SE et al.. The association of HLA-G polymorphism with oral and genital HPV infection in men. Eur J Clin Microbiol Infect Dis. 2022;41 (2):219-226. doi: 10.1007/s10096-021-04362-8. PubMed PMID:34697671 PubMed Central PMC8770419.

Search PubMed

2021

  1. Suominen, NT, Jaakola, AJ, Roger, M, Faucher, MC, Syrjänen, KJ, Grénman, SE et al.. The association of HLA-G polymorphism with oral and genital HPV infection in men. Eur J Clin Microbiol Infect Dis. 2022;41 (2):219-226. doi: 10.1007/s10096-021-04362-8. PubMed PMID:34697671 PubMed Central PMC8770419.
  2. Jaakola, A, Roger, M, Faucher, MC, Syrjänen, K, Grénman, S, Syrjänen, S et al.. HLA-G polymorphism impacts the outcome of oral HPV infections in women. BMC Infect Dis. 2021;21 (1):419. doi: 10.1186/s12879-021-06079-7. PubMed PMID:33947339 PubMed Central PMC8097798.
  3. Bergqvist, L, Kalliala, I, Aro, K, Auvinen, E, Jakobsson, M, Kiviharju, M et al.. Distribution of HPV Genotypes Differs Depending on Behavioural Factors among Young Women. Microorganisms. 2021;9 (4):. doi: 10.3390/microorganisms9040750. PubMed PMID:33918429 PubMed Central PMC8066411.
  4. Syrjänen, S, Rintala, M, Sarkola, M, Willberg, J, Rautava, J, Koskimaa, H et al.. Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland. Emerg Infect Dis. 2021;27 (3):759-766. doi: 10.3201/eid2703.202721. PubMed PMID:33513331 PubMed Central PMC7920652.
  5. Robles, C, Bruni, L, Acera, A, Riera, JC, Prats, L, Poljak, M et al.. Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries. Am J Prev Med. 2021;60 (4):478-487. doi: 10.1016/j.amepre.2020.08.032. PubMed PMID:33358719 .

Search PubMed

2020

  1. Robles, C, Bruni, L, Acera, A, Riera, JC, Prats, L, Poljak, M et al.. Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries. Am J Prev Med. 2021;60 (4):478-487. doi: 10.1016/j.amepre.2020.08.032. PubMed PMID:33358719 .
  2. Louvanto, K, Eriksson, T, Gray, P, Apter, D, Baussano, I, Bly, A et al.. Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women. Int J Cancer. 2020;147 (2):440-447. doi: 10.1002/ijc.32802. PubMed PMID:31749143 .
  3. Louvanto, K, Aro, K, Nedjai, B, Bützow, R, Jakobsson, M, Kalliala, I et al.. Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia. Clin Infect Dis. 2020;70 (12):2582-2590. doi: 10.1093/cid/ciz677. PubMed PMID:31344234 PubMed Central PMC7286376.

Search PubMed

2019

  1. Louvanto, K, Eriksson, T, Gray, P, Apter, D, Baussano, I, Bly, A et al.. Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women. Int J Cancer. 2020;147 (2):440-447. doi: 10.1002/ijc.32802. PubMed PMID:31749143 .
  2. Malagón, T, Louvanto, K, Ramanakumar, AV, Koushik, A, Coutlée, F, Franco, EL et al.. Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age. Gynecol Oncol. 2019;155 (2):245-253. doi: 10.1016/j.ygyno.2019.09.010. PubMed PMID:31604665 .
  3. Aro, K, Nieminen, P, Louvanto, K, Jakobsson, M, Virtanen, S, Lehtinen, M et al.. Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women. Gynecol Oncol. 2019;154 (2):354-359. doi: 10.1016/j.ygyno.2019.05.024. PubMed PMID:31176553 .
  4. Wissing, MD, Louvanto, K, Comète, E, Burchell, AN, El-Zein, M, Rodrigues, A et al.. Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples. J Infect Dis. 2019;220 (7):1152-1161. doi: 10.1093/infdis/jiz238. PubMed PMID:31063542 PubMed Central PMC6736425.
  5. El-Zein, M, Bouten, S, Louvanto, K, Gilbert, L, Gotlieb, WH, Hemmings, R et al.. Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions. Cancer Epidemiol Biomarkers Prev. 2019;28 (7):1134-1140. doi: 10.1158/1055-9965.EPI-18-1338. PubMed PMID:31015201 .
  6. Paaso, A, Jaakola, A, Syrjänen, S, Louvanto, K. From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity. Acta Cytol. 2019;63 (2):148-158. doi: 10.1159/000494985. PubMed PMID:30783048 .
  7. Malagón, T, Louvanto, K, Wissing, M, Burchell, AN, Tellier, PP, El-Zein, M et al.. Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study. Lancet Infect Dis. 2019;19 (3):317-326. doi: 10.1016/S1473-3099(18)30655-8. PubMed PMID:30745276 PubMed Central PMC6404546.

Search PubMed

2018

  1. El-Zein, M, Bouten, S, Louvanto, K, Gilbert, L, Gotlieb, W, Hemmings, R et al.. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study. Gynecol Oncol. 2018;149 (3):491-497. doi: 10.1016/j.ygyno.2018.04.004. PubMed PMID:29678360 .
  2. Louvanto, K, Roger, M, Faucher, MC, Syrjänen, K, Grenman, S, Syrjänen, S et al.. HLA-G and vertical mother-to-child transmission of human papillomavirus infection. Hum Immunol. 2018;79 (6):471-476. doi: 10.1016/j.humimm.2018.03.002. PubMed PMID:29544814 .
  3. Tainio, K, Athanasiou, A, Tikkinen, KAO, Aaltonen, R, Cárdenas, J, Hernándes, et al.. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360 :k499. doi: 10.1136/bmj.k499. PubMed PMID:29487049 PubMed Central PMC5826010.
  4. Faucher, MC, Louvanto, K, Syrjänen, S, Roger, M. Characterisation of the novel HLA-G null allele, HLA-G*01:21N, in Finnish individuals. HLA. 2018;91 (2):146-147. doi: 10.1111/tan.13177. PubMed PMID:29152919 .

Search PubMed